A Multicenter Phase II/III-study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer (Affibody-3).

Condition:   HER2-positive Breast Cancer Intervention:   Diagnostic Test: ABY-PET Sponsors:   Henrik Lindman;   Roche Pharma AG;   Swedish Cancer Society;   Affibody;   Swedish Breast Cancer Group Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials